12/24
06:15 am
argx
argenex (NASDAQ:ARGX) was upgraded by analysts at DZ Bank AG to a "strong-buy" rating.
Neutral
Report
argenex (NASDAQ:ARGX) was upgraded by analysts at DZ Bank AG to a "strong-buy" rating.
12/19
05:57 am
argx
argenex (NASDAQ:ARGX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Low
Report
argenex (NASDAQ:ARGX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
12/18
08:05 am
argx
argenex (NASDAQ:ARGX) had its "neutral" rating reaffirmed by analysts at Robert W. Baird. They now have a $858.00 price target on the stock, down previously from $924.00.
Low
Report
argenex (NASDAQ:ARGX) had its "neutral" rating reaffirmed by analysts at Robert W. Baird. They now have a $858.00 price target on the stock, down previously from $924.00.
12/17
10:23 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Royal Bank Of Canada from $860.00 to $925.00. They now have an "outperform" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Royal Bank Of Canada from $860.00 to $925.00. They now have an "outperform" rating on the stock.
12/15
01:00 am
argx
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
Medium
Report
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
12/11
12:31 pm
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,095.00 to $1,316.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wells Fargo & Company from $1,095.00 to $1,316.00. They now have an "overweight" rating on the stock.
12/11
08:44 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Stifel Nicolaus from $1,028.00 to $1,248.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Stifel Nicolaus from $1,028.00 to $1,248.00. They now have a "buy" rating on the stock.
12/8
11:03 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $925.00 to $1,100.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $925.00 to $1,100.00. They now have an "overweight" rating on the stock.
12/4
10:11 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Morgan Stanley from $1,070.00 to $1,110.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Morgan Stanley from $1,070.00 to $1,110.00. They now have an "overweight" rating on the stock.
11/24
08:06 am
argx
argenex (NASDAQ:ARGX) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.
Low
Report
argenex (NASDAQ:ARGX) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.
11/18
04:01 pm
argx
argenx Announces Results of Extraordinary General Meeting of Shareholders
Low
Report
argenx Announces Results of Extraordinary General Meeting of Shareholders
11/17
10:23 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Citigroup Inc. from $1,041.00 to $1,124.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Citigroup Inc. from $1,041.00 to $1,124.00. They now have a "buy" rating on the stock.
11/14
10:32 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wedbush from $880.00 to $1,000.00. They now have an "outperform" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wedbush from $880.00 to $1,000.00. They now have an "outperform" rating on the stock.
11/13
08:16 am
argx
Here's Why argenx SE (ARGX) Rose in Q3 [Yahoo! Finance]
Low
Report
Here's Why argenx SE (ARGX) Rose in Q3 [Yahoo! Finance]
11/7
03:02 pm
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $830.00 to $925.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at JPMorgan Chase & Co. from $830.00 to $925.00. They now have an "overweight" rating on the stock.
11/4
11:54 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Piper Sandler from $820.00 to $930.00. They now have an "overweight" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Piper Sandler from $820.00 to $930.00. They now have an "overweight" rating on the stock.
10/31
12:54 pm
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at TD Cowen from $800.00 to $1,146.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at TD Cowen from $800.00 to $1,146.00. They now have a "buy" rating on the stock.
10/31
11:35 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Royal Bank Of Canada from $850.00 to $860.00. They now have an "outperform" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Royal Bank Of Canada from $850.00 to $860.00. They now have an "outperform" rating on the stock.
10/31
09:25 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Evercore ISI from $775.00 to $910.00. They now have an "outperform" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Evercore ISI from $775.00 to $910.00. They now have an "outperform" rating on the stock.
10/31
08:06 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at HC Wainwright from $774.00 to $915.00. They now have a "buy" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at HC Wainwright from $774.00 to $915.00. They now have a "buy" rating on the stock.
10/30
02:00 am
argx
argenx Reports Third Quarter 2025 Financial Results and Provides Business Update
Low
Report
argenx Reports Third Quarter 2025 Financial Results and Provides Business Update
10/29
11:00 am
argx
argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
Low
Report
argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
10/23
01:00 am
argx
argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025
Low
Report
argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025
10/15
01:00 am
argx
argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session
Low
Report
argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session
10/13
09:05 am
argx
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wedbush from $800.00 to $880.00. They now have an "outperform" rating on the stock.
Low
Report
argenex (NASDAQ:ARGX) had its price target raised by analysts at Wedbush from $800.00 to $880.00. They now have an "outperform" rating on the stock.